Fenwick & West represented CoreWeave in the transaction. CoreWeave, a specialized GPU cloud provider powering the next wave of AI, announced a minority investment of $650...
CoreWeave’s $650 Million Minority Investment Round
BioAge Labs’ $238 Million Upsized Initial Public Offering
Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...
Vertex Pharmaceuticals’ Acquisition of Alpine Immune Sciences
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
SentinelOne’s Acquisition of PingSafe
Fenwick & West is representing SentinelOne in the transaction. SentinelOne (NYSE: S) announced that it has agreed to acquire PingSafe, an industry-leading cloud security platform. The...
Foresite Capital Management’s Acquisition of Pardes Biosciences
Paul, Weiss, Rifkind, Wharton & Garrison LLP is advising MediPacific, Inc., while Fenwick & West LLP is advising Pardes Biosciences, Inc. in the transaction. MediPacific, Inc.,...
Day One Biopharmaceuticals’ $150 Million Public Offering
Fenwick represented Day One Biopharmaceuticals, Inc. on the offering, while Cooley LLP represented the underwriters. Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a clinical-stage biopharmaceutical company focused...